Case number 1:21-cv-00952
Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 12, 2022 | 102 | SO ORDERED, re 101 Stipulation of Dismissal with Prejudice, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. CASE CLOSED. Signed by Judge Colm F. Connolly on 12/12/2022. (kmd) (Entered: 12/12/2022) (3) |
| Dec 12, 2022 | 103 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,572,887 B2; 11,103,483. (Attachments: # 1 Stipulation of Dismissal with Prejudice)(kmd) (Entered: 12/12/2022) (Main Document) (1) |
| Dec 12, 2022 | 103 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,572,887 B2; 11,103,483. (Attachments: # 1 Stipulation of Dismissal with Prejudice)(kmd) (Entered: 12/12/2022) (Stipulation of Dismissal with Prejudice) (3) |
| Dec 9, 2022 | 101 | STIPULATION and [Proposed] Order of Dismissal with Prejudice by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Brauerman, Stephen) (Entered: 12/09/2022) (3) |
| Nov 18, 2022 | 98 | NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Objections and Responses to Defendant's Second Set of Requests for Production (Nos. 7-18), and (2) Plaintiff Eagle Pharmaceutical's Inc.'s Objections and Responses to Defenant's First Set of Requests for Admission (Nos. 1-10) filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 11/18/2022) (3) |
| Nov 18, 2022 | 99 | NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH and Cephalon, LLCs Objections and Responses to Defendant Accord Healthcare Inc.s Second Set of Requests for Production of Documents and Things (Nos. 7-18); Teva Pharmaceuticals International GmbH and Cephalon LLCS Objections and Responses to Defendant Accord Healthcare Inc.s First Set of Requests for Admission (Nos. 1-10); and Plaintiffs Objections and Responses to Defendant Accord Healthcare Inc.s First Set of Interrogatories (Nos. 1-14) filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/18/2022) (3) |
| Nov 18, 2022 | 100 | NOTICE OF SERVICE of Accords Objections and Responses to Plaintiffs Notice of Deposition filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/18/2022) (2) |
| Nov 16, 2022 | 97 | Official Transcript of Markman Hearing held on September 15, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/7/2022. Redacted Transcript Deadline set for 12/19/2022. Release of Transcript Restriction set for 2/14/2023. (nmf) (Entered: 11/16/2022) (0) |
| Nov 15, 2022 | 95 | STIPULATION and [Proposed] Order that the parties may conduct the previously noticed depositions (D.I. 81-86, 90-94) after the November 18, 2022 close of fact discovery deadline by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 11/15/2022) (3) |
| Nov 15, 2022 | 96 | SO ORDERED, re 95 Stipulation that the parties may conduct the previously noticed depositions (D.I. 81-86, 90-94) after the November 18, 2022 close of fact discovery deadline, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 11/15/2022. (kmd) (Entered: 11/15/2022) (3) |
| Nov 11, 2022 | 90 | NOTICE to Take Deposition of Scott L. Tarriff on a date to be determined filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 11, 2022 | 91 | NOTICE to Take Deposition of Philip Christopher Buxton on a date to be determined filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 11, 2022 | 92 | NOTICE to Take Deposition of Anthony Drager on a date to be determined filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 11, 2022 | 93 | NOTICE to Take Deposition of Srikanth Sundaram on a date to be determined filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 11, 2022 | 94 | NOTICE to Take Deposition of Nagesh R. Palepu on a date to be determined filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 8, 2022 | 89 | NOTICE OF SERVICE of Eagle Pharmaceuticals Inc.'s Responses and Objections to Accord Healthcare Inc.'s Notice of Rule 30(b)(6) Deposition filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 88 | NOTICE OF SERVICE of Teva Pharmaceuticals International GMBH and Cephalon LLC's Objections and Responses to Accord Healthcare Inc.'s Notice of Rule 30(b)(6) Deposition filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/07/2022) (2) |
| Nov 4, 2022 | 87 | REDACTED VERSION of 82 Notice to Take Deposition, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 11/04/2022) (10) |
| Nov 1, 2022 | 82 | [SEALED] NOTICE to Take Deposition of Defendant Accord Healthcare Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on November 14, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Certificate of Service)(Golden, Ronald) (Entered: 11/01/2022) (0) |
| Nov 1, 2022 | 83 | NOTICE to Take Deposition of Nitin Patel on November 17, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/01/2022) (3) |
| Nov 1, 2022 | 84 | NOTICE to Take Deposition of Ajeet Singh on November 18, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/01/2022) (3) |
| Nov 1, 2022 | 85 | NOTICE to Take Deposition of Sabita Nair on November 18, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/01/2022) (3) |
| Nov 1, 2022 | 86 | NOTICE to Take Deposition of Alpesh Pathak on November 17, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 11/01/2022) (3) |
| Oct 21, 2022 | 81 | NOTICE OF SERVICE of Defendants Notice of Rule 30(b)(6) Deposition of Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GMBH, and Cephalon Inc. filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 10/21/2022) (2) |
| Oct 19, 2022 | 80 | NOTICE OF SERVICE of (1) Defendants First Set of Requests for Admission, (2) Defendants Second Set of Requests for the Production of Documents and Things (Nos. 7-18), and (3) Defendants First Set of Interrogatories (Nos. 1-14) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 10/19/2022) (3) |
| Oct 17, 2022 | 78 | NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Objections and Responses to Defendant's First Set of Requests for Production (Nos. 1-6) filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 10/17/2022) (2) |
| Oct 17, 2022 | 79 | NOTICE OF SERVICE of Plaintiffs Teva Pharmaceuticals International and Cephalon, Inc.'s Objections and Responses to Defendant Accord Healthcare Inc.'s First Set of Requests for Production (Nos. 1-6) filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 10/17/2022) (2) |
| Oct 11, 2022 | 77 | NOTICE requesting Clerk to remove Jennifer Koh as co-counsel.. (Joyce, Alexandra) (Entered: 10/11/2022) (3) |
| Oct 10, 2022 | 76 | MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Shanahan and Angela X. Gao - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Certification of Daniel P. Shanahan, # 2 Certification of Angela X. Gao)(Golden, Ronald) (Entered: 10/10/2022) (Main Document) (2) |
| Oct 10, 2022 | 76 | MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Shanahan and Angela X. Gao - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Certification of Daniel P. Shanahan, # 2 Certification of Angela X. Gao)(Golden, Ronald) (Entered: 10/10/2022) (Certification of Daniel P. Shanahan) (1) |
| Oct 10, 2022 | 76 | MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Shanahan and Angela X. Gao - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Certification of Daniel P. Shanahan, # 2 Certification of Angela X. Gao)(Golden, Ronald) (Entered: 10/10/2022) (Certification of Angela X. Gao) (1) |
| Sep 22, 2022 | 75 | CLAIM CONSTRUCTION ORDER re (95 in 1:22-cv-00042-CFC, 73 in 1:21-cv-00952-CFC, 97 in 1:21-cv-00695-CFC) Proposed Order filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/22/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/22/2022) (4) |
| Sep 21, 2022 | 73 | PROPOSED ORDER Claim Construction by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/21/2022) (4) |
| Sep 21, 2022 | 74 | NOTICE OF SERVICE of Accords First Set of Requests for Production (Nos. 1-6) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) (Entered: 09/21/2022) (2) |
| Sep 13, 2022 | 68 | SO ORDERED, re (66 in 1:21-cv-00952-CFC) (85 in 1:22-cv-00042-CFC) (90 in 1:21-cv-00695-CFC) STIPULATION TO EXTEND TIME to File Public Versions of the Joint Claim Construction Brief, Appendix to the Joint Claim Construction Brief, and Motion for Leave to File Sur-Reply to September 13, 2022, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/13/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(kmd) (Entered: 09/13/2022) (4) |
| Sep 13, 2022 | 69 | MOTION for Pro Hac Vice Appearance of Attorney David Kowalski - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (5) |
| Sep 13, 2022 | 70 | REDACTED VERSION of 61 Joint Claim Construction Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 09/13/2022) (30) |
| Sep 13, 2022 | 71 | REDACTED VERSION of 63 MOTION for Leave to File Surreply Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Golden, Ronald) (Entered: 09/13/2022) (Main Document) (8) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Main Document) (12) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 1, 2, 3, 4) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 5, 6, 7, 8, 9, 10) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 41, 42, 43, 44, 45, 46, 47, 48) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 49, 50, 51, 52) (15) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 53, 54, 55, 56, 57, 58, 59, 60) (30) |
| Sep 13, 2022 | 72 | REDACTED VERSION of 62 Appendix,, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73) (30) |
| Sep 13, 2022 | 71 | REDACTED VERSION of 63 MOTION for Leave to File Surreply Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit A) (3) |
| Sep 13, 2022 | 71 | REDACTED VERSION of 63 MOTION for Leave to File Surreply Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit B) (7) |
| Sep 13, 2022 | 71 | REDACTED VERSION of 63 MOTION for Leave to File Surreply Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Golden, Ronald) (Entered: 09/13/2022) (Exhibit C) (4) |
| Sep 9, 2022 | 65 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Golden, Ronald) (Entered: 09/09/2022) (Main Document) (19) |
| Sep 9, 2022 | 66 | STIPULATION TO EXTEND TIME to File Public Versions of the Joint Claim Construction Brief, Appendix to the Joint Claim Construction Brief, and Motion for Leave to File Sur-Reply to September 13, 2022 - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 09/09/2022) (4) |
| Sep 9, 2022 | 67 | Joint Letter to Chief Judge Colm F. Connolly from Emily S. DiBenedetto regarding Parties Meet and Confer. (Golden, Ronald) (Entered: 09/09/2022) (2) |
| Sep 9, 2022 | 65 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Golden, Ronald) (Entered: 09/09/2022) (Exhibit A) (13) |
| Sep 9, 2022 | 65 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Golden, Ronald) (Entered: 09/09/2022) (Exhibit B) (18) |
| Sep 7, 2022 | 64 | ORDER: Having read the parties' claim construction briefing (D.1. 84) and having reviewed the December 15, 2020 hearing transcript and related briefing in Eagle Pharms. Inc. v. Hospira, Inc., C.A. No. 18-1074-CFC-CJB, I will construe the claim term "a non-aqueous liquid composition" to mean "a solution in which water does not make up a substantial portion and is not a significant solvent." Oral argument for the upcoming Markman Hearing will focus solely on the disputed term "ready to use" and will be limited to one hour. Signed by Judge Colm F. Connolly on 9/7/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/07/2022) (2) |
| Sep 2, 2022 | 61 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Teva Pharmaceuticals International GmbH. (Attachments: # 1 Certificate of Service)(Golden, Ronald) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 62 | [SEALED] Joint APPENDIX re 61 Joint Claim Construction Brief by Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1, 2, 3, 4, # 2 Exhibit 5, 6, 7, 8, 9, 10, # 3 Exhibit 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, # 4 Exhibit 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, # 5 Exhibit 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, # 6 Exhibit 41, 42, 43, 44, 45, 46, 47, 48, # 7 Exhibit 49, 50, 51, 52, # 8 Exhibit 53, 54, 55, 56, 57, 58, 59, 60, # 9 Exhibit 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, # 10 Certificate of Service COS)(Golden, Ronald) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 63 | [SEALED] MOTION for Leave to File Surreply Brief - filed by Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit, # 2 Exhibit, # 3 Exhibit, # 4 Certificate of Service)(Golden, Ronald) (Entered: 09/02/2022) (0) |
| Sep 1, 2022 | 60 | STIPULATION and [Proposed] Order regarding Joint Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/01/2022) (4) |
| Aug 31, 2022 | 58 | STIPULATION to Change Name and Amend Caption by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 08/31/2022) (3) |
| Aug 31, 2022 | 59 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cupric Holding Co. LLC for Cephalon, Inc. filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Golden, Ronald) (Entered: 08/31/2022) (3) |
| Aug 15, 2022 | 57 | NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc.'s Reply Claim Construction Brief with the Exhibits thereto filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) (Entered: 08/15/2022) (2) |
| Jul 11, 2022 | 56 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc.'s Opening Claim Construction Brief and this Notice of Service filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) |
| Jul 8, 2022 | 55 | SO ORDERED (5) Docket Text: SO ORDERED, re (54 in 1:21-cv-00952-CFC, 76 in 1:21-cv-00695-CFC) STIPULATION TO EXTEND TIME (1) Opening Clain Construction Brief (2) Answering Claim Construction Brief, (3) Reply Claim Construction Brief, and (4) Sur-Reply Claim Construction Brief to (1) July 11, 2022, (2) August 1, 2022, (3) August 15, 2022, and (4) August 29, 2022, filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 7/8/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(kmd) |
| Jul 7, 2022 | 54 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME (1) Opening Clain Construction Brief (2) Answering Claim Construction Brief, (3) Reply Claim Construction Brief, and (4) Sur-Reply Claim Construction Brief to (1) July 11, 2022, (2) August 1, 2022, (3) August 15, 2022, and (4) August 29, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| Jun 17, 2022 | 52 | Main Document (18) Docket Text: CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) U.S. Patent No. 9,572,887, # (2) U.S. Patent No. 11,103,483)(Joyce, Alexandra) |
| Jun 17, 2022 | 52 | U.S. Patent No. 9,572,887 (19) |
| Jun 17, 2022 | 52 | U.S. Patent No. 11,103,483 (13) |
| Jun 17, 2022 | 53 | Main Document (3) Docket Text: MOTION for Claim Construction - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Word Count Certification, # (2) Text of Proposed Order)(Joyce, Alexandra) |
| Jun 17, 2022 | 53 | Word Count Certification (1) |
| Jun 17, 2022 | 53 | Text of Proposed Order (2) |
| Jun 13, 2022 | 51 | SO ORDERED (2) Docket Text: SO ORDERED, re [50] STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to June 17, 2022, filed by Accord Healthcare Inc. Signed by Judge Colm F. Connolly on 6/13/2022. (kmd) |
| Jun 10, 2022 | 50 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to June 17, 2022 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| May 31, 2022 | 49 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Accords Objections and Responses to Plaintiffs First Set of Requests for Production (Nos. 1-104) and (2) Accords Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-11) filed by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| May 27, 2022 | 48 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Preliminary Disclosure of Proposed Claim Terms for Construction filed by Accord Healthcare Inc., Accord Healthcare Ltd., Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| May 23, 2022 | 47 | SO ORDERED (3) Docket Text: SO ORDERED, re [46] STIPULATION TO EXTEND TIME for the Parties to Exchange Their Proposed Terms for Construction and Proposed Constructions to May 27, 2022, filed by Accord Healthcare Inc. Signed by Judge Colm F. Connolly on 5/23/2022. (kmd) |
| May 20, 2022 | 46 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Exchange Their Proposed Terms for Construction and Proposed Constructions to May 27, 2022 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| May 13, 2022 | 45 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Invalidity Contentions for U.S. Patent Nos. 9,572,887 and 11,103,483 filed by Accord Healthcare Inc., Accord Healthcare Ltd., Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| May 2, 2022 | 43 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc., Teva Pharmaceuticals International GmbH filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
| May 2, 2022 | 44 | Statement (2) Docket Text: STATEMENT regarding Third-Party Litigation Funding by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
| Apr 29, 2022 | 42 | Notice (Other) (2) Docket Text: NOTICE of Change of Firm Address of Williams & Connolly LLP by Cephalon, Inc., Teva Pharmaceuticals International GmbH (Golden, Ronald) |
| Apr 28, 2022 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc.'s First Set of Requests for Production to Defendant Accord Healthcare, Inc. and first set of Interrogatories to Defendant Accord Healthcare, Inc. filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) |
| Apr 21, 2022 | 40 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Angela C. Whitesell as Counsel by Eagle Pharmaceuticals, Inc. (Whitesell, Angela) |
| Apr 6, 2022 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH, Cephalon, Inc. and Eagle Pharmaceuticals, Inc.'s Infringement Contentions filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) |
| Apr 5, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The PROPOSED Amended Protective Order, filed by Teva Pharmaceuticals International GmbH on 4/4/2022, has been removed from the docket. The proposed order should be re-filed with corrected pagination. (kmd) |
| Apr 5, 2022 | 37 | Proposed Order (30) Docket Text: PROPOSED ORDER Amended Protective Order by Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
| Apr 5, 2022 | 38 | Protective Order (30) Docket Text: AMENDED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(kmd) |
| Apr 4, 2022 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a), and (2) Eagle Pharmaceutical Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) |
| Apr 4, 2022 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard and Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) |
| Apr 4, 2022 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Accord Healthcare, Inc.s Rule 26(a)(1) Initial Disclosures and (2) Defendant Accord Healthcare, Inc.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| Mar 29, 2022 | 32 | Scheduling Order (4) Docket Text: STIPULATED SCHEDULING ORDER: Joinder of Parties due by 5/18/2022. Amended Pleadings due by 5/18/2022. A Bench Trial is set for 5/1/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. See stipulated order for further details. Signed by Judge Colm F. Connolly on 3/28/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(nmf) |
| Mar 16, 2022 | 31 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Stephen B. Brauerman regarding Proposed Scheduling Order - re [26] Order,, Set Deadlines,. (Attachments: # (1) Stipulation and [Proposed] Order)(Brauerman, Stephen) |
| Mar 16, 2022 | 31 | Stipulation and [Proposed] Order (4) |
| Mar 9, 2022 | 30 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Eagle Pharmaceuticals, Inc.: Entry of appearance of attorney Daniel M. Silver. Attorney Stephen Brauerman, Esq. and Ronald Golden, III, Esq. terminated. (Silver, Daniel) |
| Feb 28, 2022 | 28 | Answer to Counterclaim (6) Docket Text: ANSWER to [24] Answer to Amended Complaint, Counterclaim / Plaintiffs' Answer to Accord's Counterclaims by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Golden, Ronald) |
| Feb 16, 2022 | 26 | Order (1) Docket Text: ORDER; IT IS ORDERED that, on or before March 16, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/16/2022.) Signed by Judge Colm F. Connolly on 2/16/2022. (nmf) |
| Feb 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] STIPULATION TO EXTEND TIME to respond to Plaintiffs First Amended Complaint to February 11, 2022, filed by Accord Healthcare Inc. Reset Answer Deadlines: Accord Healthcare Inc. answer due 2/11/2022. Ordered by Judge Colm F. Connolly on 2/11/2022. (kmd) |
| Feb 10, 2022 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to respond to Plaintiffs First Amended Complaint to February 11, 2022 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Feb 10, 2022 | 24 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [21] Amended Complaint , COUNTERCLAIM against Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH by Accord Healthcare Inc..(Stamoulis, Stamatios) |
| Jan 26, 2022 | 21 | Main Document (19) Docket Text: First AMENDED COMPLAINT against Accord Healthcare Inc.- filed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Golden, Ronald) |
| Jan 26, 2022 | 21 | Exhibit A (18) |
| Jan 26, 2022 | 21 | Exhibit B (13) |
| Jan 26, 2022 | 22 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,572,887 B2 ;11,103,483 . (Golden, Ronald) |
| Jan 26, 2022 | 21 | Amended Complaint* (1) |
| Jan 24, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Wesley E. Weeks, Corey Weinstein, and Neal Seth for Accord Healthcare Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) |
| Jan 19, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, and Corey Weinstein, filed by Accord Healthcare Inc. Ordered by Judge Colm F. Connolly on 1/19/2022. (kmd) |
| Jan 19, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Daniel G. Brown, and Jennifer Koh, filed by Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 1/19/2022. (kmd) |
| Jan 19, 2022 | 20 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Daniel G. Brown, and Jennifer Koh - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) [Proposed] Order, # (2) Certification of Alex Grabowski, # (3) Certification of Marc N. Zubick, # (4) Certification of Kenneth G. Schuler, # (5) Certification of Jennifer Koh, # (6) Certification of Daniel G. Brown)(Golden, Ronald) |
| Jan 19, 2022 | 20 | [Proposed] Order (1) |
| Jan 19, 2022 | 20 | Certification of Alex Grabowski (1) |
| Jan 19, 2022 | 20 | Certification of Marc N. Zubick (1) |
| Jan 19, 2022 | 20 | Certification of Kenneth G. Schuler (1) |
| Jan 19, 2022 | 20 | Certification of Jennifer Koh (1) |
| Jan 19, 2022 | 20 | Certification of Daniel G. Brown (1) |
| Jan 18, 2022 | 18 | Redacted Document (21) Docket Text: REDACTED VERSION of [16] Opening Brief in Support, by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Jan 18, 2022 | 19 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, and Corey Weinstein - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Jan 13, 2022 | 15 | Main Document (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Accord Healthcare Inc.. (Attachments: # (1) Text of Proposed Order)(Stamoulis, Stamatios) |
| Jan 13, 2022 | 15 | Text of Proposed Order (1) |
| Jan 13, 2022 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Intas Pharmaceuticals Ltd. for Accord Healthcare Inc. filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Nov 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] Third STIPULATION TO EXTEND TIME for Defendant to Answer Plaintiff's Complaint to January 13, 2022, filed by Accord Healthcare Inc. Reset Answer Deadlines: Accord Healthcare Inc. answer due 1/13/2022. Ordered by Judge Colm F. Connolly on 11/29/2021. (kmd) |
| Nov 24, 2021 | 14 | Stipulation to EXTEND Time (2) Docket Text: Third STIPULATION TO EXTEND TIME for Defendant to Answer Plaintiff's Complaint to January 13, 2022 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Oct 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] Second STIPULATION TO EXTEND TIME for Defendant to respon to December 1, 2021 filed by Accord Healthcare Inc. Set/Reset Answer Deadlines: Accord Healthcare Inc. answer due 12/1/2021. Ordered by Judge Colm F. Connolly on 10/26/2021. (kmd) |
| Oct 25, 2021 | 13 | Stipulation to EXTEND Time (2) Docket Text: Second STIPULATION TO EXTEND TIME for Defendant to respon to December 1, 2021 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Sep 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME for Defendant to answer Plaintiff's Complaint to October 28, 2021 filed by Accord Healthcare Inc. Set/Reset Answer Deadlines: Accord Healthcare Inc. answer due 10/28/2021. Signed by Judge Colm F. Connolly on 9/28/2021. (kmd) |
| Sep 27, 2021 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant to answer Plaintiff's Complaint to October 28, 2021 - filed by Accord Healthcare Inc.. (Stamoulis, Stamatios) |
| Aug 2, 2021 | 11 | SO ORDERED (5) Docket Text: SO ORDERED, re [9] STIPULATION TO EXTEND TIME for Defendant Accord Healthcare, Inc. to Respond to Plaintiffs' Complaint to September 28, 2021 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Party Accord Healthcare Ltd. and Intas Pharmaceuticals Ltd. terminated. Set/Reset Answer Deadlines: Accord Healthcare Inc. answer due 9/28/2021. Signed by Judge Colm F. Connolly on 8/2/2021. (fms) |
| Jul 30, 2021 | 9 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for Defendant Accord Healthcare, Inc. to Respond to Plaintiffs' Complaint to September 28, 2021 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Brauerman, Stephen) |
| Jul 30, 2021 | 10 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Stamatios Stamoulis on behalf of Accord Healthcare Inc., Accord Healthcare Ltd. (Stamoulis, Stamatios) |
| Jul 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber and Ben Picozzi of Williams & Connolly LLP filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 7/12/2021. (fms) |
| Jul 12, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney David I. Berl, Ben V. Picozzi, Adam D. Harber for Cephalon, Inc., for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 12, 2021 | 8 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber and Ben Picozzi of Williams & Connolly LLP - filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
| Jul 7, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jun 30, 2021 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (smg) |
| Jun 30, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (Brauerman, Stephen) |
| Jun 30, 2021 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Cephalon, Inc. filed by Cephalon, Inc.. (Brauerman, Stephen) |
| Jun 30, 2021 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc., Other Affiliate Janus Henderson Group PLC for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc.. (Brauerman, Stephen) |
| Jun 29, 2021 | 1 | Main Document (63) Docket Text: COMPLAINT filed against Accord Healthcare Inc., Accord Healthcare Ltd., Intas Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3646929.) - filed by Teva Pharmaceuticals International GmbH, Cephalon, Inc., Eagle Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Civil Cover Sheet)(smg) |
| Jun 29, 2021 | 1 | Exhibit A (11) |
| Jun 29, 2021 | 1 | Exhibit B (9) |
| Jun 29, 2021 | 1 | Exhibit C (10) |
| Jun 29, 2021 | 1 | Exhibit D (10) |
| Jun 29, 2021 | 1 | Exhibit E (13) |
| Jun 29, 2021 | 1 | Exhibit F (12) |
| Jun 29, 2021 | 1 | Exhibit G (18) |
| Jun 29, 2021 | 1 | Exhibit H (13) |
| Jun 29, 2021 | 1 | Exhibit I (13) |
| Jun 29, 2021 | 1 | Exhibit J (13) |
| Jun 29, 2021 | 1 | Exhibit K (7) |
| Jun 29, 2021 | 1 | Exhibit L (8) |
| Jun 29, 2021 | 1 | Exhibit M (12) |
| Jun 29, 2021 | 1 | Exhibit N (13) |
| Jun 29, 2021 | 1 | Civil Cover Sheet (3) |
| Jun 29, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jun 29, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 17, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/17/2023. (smg) |
| Jun 29, 2021 | 4 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (smg) |
| Jun 29, 2021 | 1 | Complaint* (1) |
